The Background: Each year Congress must develop and pass appropriations bills to fund the government for the new fiscal year (FY) beginning October 1. In December, Congress passed a Continuing Resolution (CR) to fund the government at FY 2024 levels through March 14. It’s important that Congress pass a full FY 2025 funding bill to limit the impact of flat funding on cancer research planning.

The Ask: For FY 2025, the broader medical and cancer research communities, asks Congress to support the goals of the NCI’s new National Cancer Plan by providing sustainable, long-term funding for biomedical and cancer research.

Why it Matters: ASCO stands ready and eager to work with the NIH, NCI and the entire cancer community to end cancer as we know it, and our funding request for the NIH and NCI is the first step. This year, a difficult budget environment coupled with an election year has added pressure on the appropriations process. It’s vital that we continue to highlight the need for robust federal funding for cancer research.

ACT NOW >